ST. LOUIS, Mo. (First Alert 4) -Washington University researchers are studying antibody drugs that can be a game-changer for Alzheimer’s research and for those more likely to get the disease.

Two medicines have been approved that can slow cognitive decline in patients with early symptoms.

But what if the medicine is used before the symptoms present themselves?

You can learn more about this research tomorrow on CBS News Sunday Morning.

See Full Page